COMMUNIQUÉS West-GlobeNewswire

Merus Announces Second Quarter 2017 Financial Results and Highlights Recent Progress
19/09/2017
Merus Announces Second Quarter 2017 Financial Results and Highlights Recent Progress UTRECHT, The Netherlands, Sept. 19, 2017 (GLOBE NEWSWIRE) -- Merus N.V. (NASDAQ:MRUS), a clinical-stage immuno-oncology company [...]
Participation de Nicox à la conférence annuelle Cantor Fitzgerald 2017 Global Healthcare
19/09/2017
Participation de Nicox à la conférence annuelle Cantor Fitzgerald 2017 Global Healthcare 19 septembre 2017 Sophia Antipolis, France Nicox S.A. (Euronext Paris : FR0013018124, COX, éligible PEA-PME), société [...]
Nicox to present at the Cantor Fitzgerald 2017 Global Healthcare Conference
19/09/2017
Nicox to present at the Cantor Fitzgerald 2017 Global Healthcare Conference September 19, 2017 Sophia Antipolis, France Nicox S.A. (Euronext Paris: FR0013018124, COX), the international ophthalmic R&D company, today [...]
EDAP Announces Opening of two New Ablatherm-HIFU Excellence Urology Centers in the U.S.
19/09/2017
University of Chicago Medicine - Dr. A. Shalhav, Chair of Urology Surgery and Director of Robotic Surgery Vituro Health LLC - Dr. S. Scionti, Medical Director and Director of The Scionti Prostate Center in Sarasota, FL [...]
Novavax Initiates Phase 1/2 Trial of NanoFlu(TM) Vaccine in Older Adults
19/09/2017
Recently published NanoFlu(TM) preclinical data provide strong rationale for Phase 1/2 clinical trial based on robust antibody titers and improved protective responses against both current and drifted strains Data from [...]
Unlimited SharePoint migration, a real game changer for IT pros! Jump to Office 365!
19/09/2017
Cloudiway is known for its SaaS migration platform - apps.cloudiway.com - a smart tool, powerful and user-friendly to fully automate migration processes and easily move data, contents and users to the cloud. The growing [...]
Verona Pharma plc : Miscellaneous
19/09/2017
Issue of Shares September 19, 2017, London - Verona Pharma plc (AIM:VRP) (NASDAQ:VRNA) ("Verona Pharma"), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for [...]
ProMIS Neurosciences Announces Successful Humanization of Lead Product Candidate PMN310 for Alzheimer's Disease
19/09/2017
Clinical trials evaluating PMN310 expected to initiate in 2019 TORONTO and CAMBRIDGE, Mass. - September 19, 2017 - ProMIS Neurosciences, Inc., a company focused on discovery and development of precision treatments for [...]
MPI - LiPlaCis Phase 2 Recruitment Ongoing in DRP Screened Breast Cancer Patients: Relevant Clinical Benefits in 3 out of 5 Treated Patients
19/09/2017
Hoersholm, Denmark, September 19, 2017 - Medical Prognosis Institute A/S ("MPI") today announced early data from Oncology Ventures (a spinout from MPI) ongoing LiPlaCis® Phase 1/2 study show response and clinical [...]
Dangote Foundation, GBCHealth, join forces to build Coalition on Health
19/09/2017
NEW YORK, Sept. 19, 2017 (GLOBE NEWSWIRE) -- Dangote Foundation ( www.Dangote.com ) and GBCHealth have joined forces to forge a new model of partnership, African Business Coalition on Health (GBCHealth) in Africa. [...]
Glycotope outlicenses GlycoExpress® Cell Line to Airway Therapeutics
19/09/2017
Glycotope outlicenses GlycoExpress® Cell Line to Airway Therapeutics Berlin, Germany, 19 September 2017 - Glycotope GmbH [Glycotope], a clinical-stage immuno-oncology company built on world-leading glyco-biology [...]
FIT Biotech: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares
19/09/2017
FIT Biotech Oy Company release September 19, 2017 at 10:00 AM EET Conversion of FIT Biotech Oy's Convertible Capital Notes into shares Related to Convertible Note and Warrant Programmes established on September 26, 2016 [...]
TiGenix Business and Financial Update for the First Half 2017
19/09/2017
PRESS RELEASE Regulated information TiGenix Business and Financial Update for the First Half 2017 (Conference call and webcast today at 15:00 CET) Leuven (BELGIUM) - September 19, 2017, 07:00h CET - TiGenix NV (Euronext [...]
Rapport d'activité et rapport financier de TiGenix pour le premier semestre de 2017
19/09/2017
COMMUNIQUÉ DE PRESSE INFORMATIONS RÈGLEMENTÉES Rapport d'activité et rapport financier de TiGenix pour le premier semestre de 2017 (Conférence téléphonique et webdiffusion aujourd'hui à 15h CET) Louvain (BELGIQUE) - 19 [...]
Summit Therapeutics Announces Closing of its ADS Public Offering Raising USD20.1M Before Expenses
18/09/2017
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN OR INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION Summit Therapeutics plc (" [...]
Sanofi : Disclosure of trading in own shares
18/09/2017
Reporting EN This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients. The issuer of this announcement warrants that they are solely responsible for the content, [...]
Sanofi : Déclaration des transactions sur actions propres
18/09/2017
Reporting FR This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients. The issuer of this announcement warrants that they are solely responsible for the content, [...]
Ossur Hf : Transactions in relation to share buyback program
18/09/2017
Announcement from Össur hf. No. 67/2017 Reykjavík, 18 September 2017 On 15 August 2017, Össur hf. initiated a share buy-back program, see Company announcement no. 59/2017. The purpose of the share buyback program is to [...]
Novo Nordisk A/S - Share repurchase programme
18/09/2017
Bagsværd, Denmark, 18 September 2017 - On 2 February 2017, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No. 596/2014 of the European Parliament and Council of 16 April [...]

Pages